Radiotherapie stereotaxique des metastases cerebrales: experience lausannoise. [Stereotaxic radiotherapy of brain metastases: experiences in Lausanne]

Details

Serval ID
serval:BIB_A2AB8888DB34
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Radiotherapie stereotaxique des metastases cerebrales: experience lausannoise. [Stereotaxic radiotherapy of brain metastases: experiences in Lausanne]
Journal
Schweizerische Medizinische Wochenschrift
Author(s)
Zouhair  A., Tercier  P. A., Fankhauser  H., Raimondi  S., Ozsahin  M., Coucke  P. A.
ISSN
0036-7672 (Print)
Publication state
Published
Issued date
10/1997
Volume
127
Number
40
Pages
1652-6
Notes
English Abstract
Journal Article --- Old month value: Oct 4
Abstract
We report the first series of patients treated by stereotactic radiation therapy for brain metastases in Switzerland. From August 1993 to December 1994, 19 patients were treated using a linear accelerator adapted for stereotactic treatment set-up. Most of the patients received combined treatment including external irradiation. The crude overall control rate for brain metastases was 79%. Median survival was 12.2 months. Overall survival at one year was 50 +/- 12%. These data compare reasonably well with the reported median survival of 3-6 months using external cranial irradiation alone. There was no "late toxicity". The data thus indicate that stereotactic radiation therapy combined with external whole brain irradiation appears to increase life expectancy and quality of life in a selected cohort of patients.
Keywords
Actuarial Analysis Adult Aged Aged, 80 and over Brain Neoplasms/mortality/radiotherapy/*secondary/surgery Combined Modality Therapy Female Follow-Up Studies Humans Male Middle Aged *Radiosurgery Radiotherapy, Adjuvant Survival Rate
Pubmed
Web of science
Create date
24/01/2008 17:20
Last modification date
20/08/2019 15:08
Usage data